Butera Samuele 4

What Happened

• Samuele Butera, Senior Vice President & GM, Global Respiratory at INSMED (INSM), received equity awards on June 23, 2026. The filing reports 7,342 restricted stock units (RSUs) and 12,570 derivative equity awards (stock options/other contingent awards), all granted as compensation and issued for no cash consideration. No shares were sold — these are grants, not open-market purchases or sales.

Key Details

• Transaction date: 2026-06-23; SEC filing date: 2026-06-24 (timely).
• Awards: 7,342 RSUs and 12,570 derivative equity awards; reported acquisition price: $0.00 (granted for no consideration).
• Vesting (per footnotes): RSUs vest 25% on the first anniversary of the grant and 25% on each subsequent anniversary until fully vested. Stock options vest 25% at the Initial Vesting Date, then 12.5% every six months thereafter until fully vested.
• Shares owned after the transaction: not specified in the provided filing details.
• No 10b5-1 plan, tax-withholding sale, or late filing noted in the provided information.

Context

• RSUs convert to common stock as they vest; they are compensation, not immediate cash. Stock options (derivative awards) give the right to buy shares according to the stated vesting schedule and do not represent exercised or sold shares at grant.
• Grants to executives are common as retention and incentive compensation and do not by themselves indicate an insider buying or selling shares on the open market.